Neurology Health Care News Articles

LATEST ARTICLES

Hot Topics In Neuropathic Pain: Progress and Possibilities

In the United States, 2% to 3% of the population is affected by neuropathic pain, with postherpetic neuralgia and diabetic peripheral neuropathic pain being the most common. Symptoms include allodynia, paresthesia, and hyperalgesia, as well as partial or complete loss of sensation and muscle weakness. The impact of neuropathic pain on a patient's quality of life is overwhelmingly negative.

Preventing Adverse Consequences of Sleep Loss and Excessive Sleepiness: Practical Assessment and Management Strategies

Sleep loss may result from poor sleep "hygiene" or may be self-imposed as a result of economic or societal pressures. Small amounts of sleep loss may go unrecognized, but over time loss of sleep is cumulative, and can have negative effects on cognitive functioning, psychological well-being, and physical health.

Fampridine-SR: A potassium-channel blocker for the improvement of walking ability in patients with MS

Fampridine-SR is a sustained-release oral medication that is pending FDA approval for the symptomatic treatment of multiple sclerosis (MS).

An evidence-based review of the AMA/AHA guideline for the primary prevention of ischemic stroke

This review summarizes the recently published guideline on primary prevention of ischemic stroke, focusing on recommendations applicable to the geriatric population and on assessing and treating modifiable risk factors.

Multiple Sclerosis Case 2: Ms MW, a 38-Year-Old Woman Diagnosed With MS 8 Years Ago

Multiple sclerosis (MS) is a severely disabling, chronic condition that often strikes adults in the prime of their lives. Those suffering from MS may require permanent and continual therapy to maintain or optimize their functional capacities.